{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Impact Of Ivabradine in Post-COVID POTS: The Recover-Autonomic Trial","description":" The Recover-Autonomic Trial evaluates the impact of ivabradine on orthostatic intolerance, quality of life, and heart rate in patients with post-COVID postural orthostatic tachycardia syndrome (POTS). Recognizing that POTS disproportionately affects women, the study addresses a growing clinical need for targeted management strategies in this population. It examines ivabradine as part of a broader treatment approach that combines pharmacotherapy with lifestyle modifications, which together are associated with improved patient outcomes. The trial aims to inform more effective, evidence-based care for individuals experiencing persistent autonomic dysfunction following COVID-19.&amp;nbsp;   In this interview,&amp;nbsp;Thomas F. Deering, MD,&amp;nbsp;FACC&amp;nbsp;and\u202fPam Taub, MD, FACC&amp;nbsp;discuss&amp;nbsp;the Recover-Autonomic Trial.&amp;nbsp;  ","author_name":"ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research","author_url":"http:\/\/accelaccorg.libsyn.com\/website","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41862315\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/203499115"}